Press Releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Jan 21, 2014
Cipher Pharmaceuticals Inc. (TSX: DND) ("Cipher" or "the Company") today announced that its marketing partner for Absoricaä has reached a cumulative sales milestone in accordance with the...
-
Dec 30, 2013
Cipher Pharmaceuticals Inc. (TSX: DND) ("Cipher" or "the Company") today announced that William (Bill) Garriock has resigned from his position of Chair of Cipher, effective December 31, 2013, as...
-
Oct 30, 2013
Revenue increases to $5.6 million and earnings per share rise to $0.14 Toronto Stock Exchange Symbol: DND MISSISSAUGA,, ON, Oct. 30, 2013 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: DND) ("Cipher")...
-
Oct 22, 2013
Cipher Pharmaceuticals Inc. (TSX: DND) (OTC: CPHMF), today announced it will host a conference call for its Q3 2013 financial results on Wednesday, October 30, 2013. Q3 2013 CONFERENCE CALL WHEN:...
-
Sep 19, 2013
Cipher Pharmaceuticals Inc. (TSX: DND) ("Cipher") today announced that its sales and distribution partner, Ranbaxy Laboratories Inc. ("Ranbaxy") has received a Paragraph IV Certification Notice of...